FIELD: experimental medicine, biology.
SUBSTANCE: the present innovation deals with modeling experimental amyloidosis in animals with the purpose to obtain the chance for studying pathogenesis, prophylaxis and therapy. So, one should subcutaneously inject native egg albumin for animals every other day per 1 ml for 30 d. The innovation provides increased possibilities for modeling experimental amyloidosis at predominant splenic, hepatic and renal lesions for studying their functional state and circulation system, mineral exchange and other parameters associated with sodium impact and its detection.
EFFECT: higher efficiency of modeling.
1 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF SIMULATING AMYLOIDOSIS IN ANIMALS | 2008 |
|
RU2373581C1 |
METHOD OF MODELLING EXPERIMENTAL AMYLOIDOSIS IN RATS | 2009 |
|
RU2410761C1 |
METHOD OF EXPERIMENTAL AMYLOIDOSIS MODELLING IN ANIMALS | 2007 |
|
RU2347279C1 |
METHOD FOR MODELING EXPERIMENTAL AMYLOIDOSIS IN ANIMALS | 2006 |
|
RU2306617C1 |
METHOD FOR SIMULATING GENERALISED AMYLOIDOSIS IN ANIMALS | 2013 |
|
RU2536556C2 |
METHOD FOR SIMULATING EXPERIMENTAL AMYLOID DISEASE IN ANIMALS | 2014 |
|
RU2572721C1 |
METHOD FOR SIMULATION OF EXPERIMENTAL AMYLOIDOSIS IN ANIMALS | 2010 |
|
RU2446482C1 |
METHOD OF PREVENTING SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATIC FORM IN EXPERIMENTAL ANIMALS | 2009 |
|
RU2410764C1 |
METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATHIC CONDITION IN EXPERIMENTAL ANIMALS | 2008 |
|
RU2386415C1 |
METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATIC FORM IN EXPERIMENTAL ANIMALS | 2008 |
|
RU2381797C1 |
Authors
Dates
2006-02-10—Published
2004-09-15—Filed